Nukkleus (NASDAQ:DFNS – Get Free Report) issued its earnings results on Wednesday. The company reported ($1.14) earnings per share (EPS) for the quarter, Zacks reports.
Nukkleus Price Performance
NASDAQ:DFNS traded up $0.00 during trading hours on Wednesday, hitting $0.37. The company had a trading volume of 1,757,475 shares, compared to its average volume of 2,209,820. The company has a market capitalization of $13.87 million, a PE ratio of 0.02 and a beta of -5.98. The stock has a 50-day moving average price of $0.71 and a 200 day moving average price of $2.84. Nukkleus has a 52 week low of $0.33 and a 52 week high of $26.21.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on DFNS shares. Weiss Ratings restated a “sell (d+)” rating on shares of Nukkleus in a report on Monday, March 23rd. Wall Street Zen cut shares of Nukkleus from a “hold” rating to a “sell” rating in a report on Saturday, April 18th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Nukkleus currently has an average rating of “Sell”.
Institutional Trading of Nukkleus
A number of hedge funds have recently modified their holdings of the business. UBS Group AG increased its stake in Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after purchasing an additional 15,223 shares in the last quarter. Geode Capital Management LLC increased its stake in Nukkleus by 193.7% during the 4th quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock valued at $503,000 after purchasing an additional 82,252 shares in the last quarter. LPL Financial LLC bought a new stake in Nukkleus during the 4th quarter valued at about $120,000. Ausdal Financial Partners Inc. bought a new stake in Nukkleus during the 3rd quarter valued at about $105,000. Finally, Engineers Gate Manager LP purchased a new position in Nukkleus in the 4th quarter worth about $96,000. Institutional investors own 12.47% of the company’s stock.
Nukkleus Company Profile
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.
Read More
- Five stocks we like better than Nukkleus
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.
